...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).
【24h】

Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).

机译:实时肿瘤跟踪放射治疗(RTRT)治疗的前列腺和肝脏中内部基准金标记的配准准确性和可能的​​迁移。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: We have developed a linear accelerator synchronized with a fluoroscopic real-time tumor-tracking system to reduce errors due to setup and organ motion. In the real-time tumor-tracking radiation therapy (RTRT) system, the accuracy of tumor tracking depends on the registration of the marker's coordinates. The registration accuracy and possible migration of the internal fiducial gold marker implanted into prostate and liver was investigated.MATERIALS AND METHODS: Internal fiducial gold markers were implanted in 14 patients with prostate cancer and four patients with liver tumors. Computed tomography (CT) was carried out as a part of treatment planning in the 18 patients. A total of 72 follow-up CT scans were taken. We calculated the relative relationship between the coordinates of the center of mass (CM) of the organs and those of the marker. The discrepancy in the CM coordinates during a follow-up CT compared to those recorded during the planning CT was used to study possible marker migration.RESULTS: The standard deviation (SD) of interobserver variations in the CM coordinates was within 2.0 and 0.4 mm for the organ and the marker, respectively, in seven observers. Assuming that organs do not shrink, grow, or rotate, the maximum SD of migration error in each direction was estimated to be less than 2.5 and 2.0 mm for liver and prostate, respectively. There was no correlation between the marker position and the time after implantation.CONCLUSION: The degree of possible migration of the internal fiducial marker was within the limits of accuracy of the CT measurement. Most of the marker movement can be attributed to the measurement uncertainty, which also influences registration in actual treatment planning. Thus, even with the gold marker and RTRT system, a planning target volume margin should be used to account for registration uncertainty.
机译:背景与目的:我们开发了一种与荧光实时肿瘤追踪系统同步的线性加速器,以减少由于安装和器官运动而引起的错误。在实时肿瘤追踪放射治疗(RTRT)系统中,肿瘤追踪的准确性取决于标记坐标的配准。材料和方法:14例前列腺癌患者和4例肝肿瘤患者中植入了内部基准金标志物。在18位患者中,计算机断层扫描(CT)是治疗计划的一部分。总共进行了72次随访CT扫描。我们计算了器官的质心(CM)坐标与标记的坐标之间的相对关系。随访CT期间CM坐标与计划CT记录的CM差异被用于研究可能的标记移动。结果:CM坐标下观察者间差异的标准偏差(SD)在2.0和0.4 mm之内器官和标记分别在七个观察员中进行。假设器官没有收缩,生长或旋转,则肝脏和前列腺在每个方向上的迁移误差的最大SD分别估计小于2.5和2.0 mm。结论:标志物的位置与植入后的时间无相关性。结论:内部基准标志物的可能迁移程度在CT测量的精度范围内。标记物移动的大部分可归因于测量不确定度,这也影响实际治疗计划中的配准。因此,即使使用黄金标记和RTRT系统,也应使用计划目标体积余量来解决套准不确定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号